PBC treatment Ocaliva leaves U.S. market amid safety concerns
Intercept Pharmaceuticals has voluntarily withdrawn Ocaliva (obeticholic…
Cholangitis is a liver condition characterized by inflammation in the bile ducts, most commonly caused by a bacterial infection but also may develop due to a variety of other causes.
Read moreA variety of treatments may be used to treat cholangitis, depending on the type and whether it is acute or chronic.
Read moreIntercept Pharmaceuticals has voluntarily withdrawn Ocaliva (obeticholic…
Members of the primary biliary cholangitis (PBC) community…